🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To determine the safety of administering anakinra plus the physician's chem...
Status
Completed
Location
Baylor University Medical Center
Start Date
2012-12
Trial ID
NCT01802970
Treatments Being Tested
This is a phase Ib/II, open-label multicentre study to assess the safety, t...
Status
Completed
Location
Research Site
Start Date
2018-02-07
Trial ID
NCT03421353
Treatments Being Tested
This study is designed to determine the efficacy and safety of durvalumab a...
Status
Active Not Recruiting
Location
Research Site
Start Date
2018-12-27
Trial ID
NCT03819465
MARIO-3 is a Phase 2 multi-arm combination cohort study designed to evaluat...
Status
Unknown
Location
Ironwood Cancer and Research Center
Start Date
2019-12-17
Trial ID
NCT03961698
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as paclitaxel, work in differen...
Status
Completed
Location
UCSF Helen Diller Family Comprehensive Cancer Center
Start Date
2006-02
Trial ID
NCT00313599
Treatments Being Tested
This is a Phase 1, open-label, dose-escalation, and dose-expansion, with a ...
Status
Active Not Recruiting
Location
Research Site
Start Date
2019-11-06
Trial ID
NCT04104672
Treatments Being Tested
This is a study consisting of four cohorts in this setting. In Cohort 1, th...
Status
Completed
Location
Pacific Shores Medical Group
Start Date
2018-02-13
Trial ID
NCT03800836
Treatments Being Tested
The purpose of this study is to learn about the safety and effects of the s...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2024-12-10
Trial ID
NCT06704724
The hypothesis of the CA048-001 Phase 1 clinical trial is targeting multipl...
Status
Completed
Location
Local Institution
Start Date
2020-09-22
Trial ID
NCT04132817
Treatments Being Tested
Pancreatic ductal adenocarcinoma (PDAC) exhibits significant heterogeneity,...
Status
Not Yet Recruiting
Location
Hôpital Beaujon
Start Date
2026-06
Trial ID
NCT07616362
Treatments Being Tested